FDA Looks To Lead World In Post-Market Device Surveillance With Safety Plan, Investments
Executive Summary
US FDA Nov. 20 announced plans for a broad series of updates to its Medical Device Safety Action Plan for the next several months, with the goal that FDA "is consistently first among the world’s regulatory agencies to identify and act upon safety signals related to medical devices.
You may also be interested in...
Scott Gottlieb Calls It Quits After An Active Tenure At US FDA
The commissioner says he will step down next month, leaving a legacy of active policy development, but also a lot of initiatives and pilot projects that are in the middle of being implemented.
After A Year Of Pelvic Mesh Criticism, US FDA Calls Meeting To Discuss The Beleaguered Products
Following a number of reports and a major documentary criticizing the use of surgical mesh in transvaginal surgeries, regulators are calling on an expert panel and other stakeholders to provide recommendations on their safety and effectiveness.
FDA Marches Forward With 'STeP' Program To Aid Development Of Significantly Safer Medtech Products
The US agency is planning to launch another accelerated device approval program along the lines of its successful Breakthrough Devices Program. But this one, the Safer Technology Program (STeP), would focus on devices with enhanced safety features.